Evidence map›Paper›PMID 35733608›Full record

ArticlePreventive medicine reports2022

Awareness of human papillomavirus and reported human papillomavirus vaccine uptake in a high-risk population.

Trisha L Amboree, Jane R Montealegre, Paige Padgett Wermuth, Osaro Mgbere, Kayo Fujimoto, Charles Darkoh

Open access · goldAbstract read
In one paragraph

Article in Preventive medicine reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. HPV Workshop for Underserved High School Students.Journal of cancer education : the official journal of the American Association for Cancer Education · 2025
    Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Trisha L AmboreeDepartment of Management, Policy, and Community Health, The University of Texas Health Science Center at Houston, School of Public Health, Houston, TX, USA.
Jane R MontealegreDan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Paige Padgett WermuthDepartment of Management, Policy, and Community Health, The University of Texas Health Science Center at Houston, School of Public Health, Houston, TX, USA.
Osaro MgbereDisease Prevention and Control Division, Houston Health Department, Houston, TX, USA.
Kayo FujimotoDepartment of Health Promotion and Behavioral Sciences, The University of Texas Health Science Center at Houston, School of Public Health, Houston, TX, USA.
Charles DarkohDepartment of Epidemiology, Human Genetics, and Environmental Sciences, Center for Infectious Diseases, The University of Texas Health Science Center at Houston, School of Public Health, Houston, TX, USA.
The University of Texas Health Science Center at Houston · USBaylor College of Medicine · USHouston Health and Human Services Department · US

Funding

Characterizing Vancomycin-Resistant C. difficile Strains at Two Geographically Distinct LocationsR01AI150685 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI DARKOH, CHARLES · 2021 to 2025
$3.4M
Targeting the Toxins: A Novel Non-Antimicrobial Approach to Combat Clostridium difficile infectionsR01AI116914 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI DARKOH, CHARLES · 2015 to 2019
$1.9M
NIAID NIH HHS L30 AI126518NIAID NIH HHS R01 AI116914NIAID NIH HHS R01 AI150685
6 · The paper itself

Abstract

Introduction: Disparities in human papillomavirus (HPV) awareness and HPV vaccine uptake are likely exacerbated among racial/ethnic minority populations living in low-income areas. This study aims to determine the prevalence and correlates of HPV awareness and HPV vaccine uptake in an urban, low-income, racial/ethnic minority population. Methods: Secondary data analyses were performed in 2021 using 380 participants aged 18-45 years from the 2019 National HIV Behavioral Surveillance for high-risk heterosexuals, which monitors HIV risk behaviors among individuals living in high-poverty, high HIV prevalence neighborhoods. Prevalence estimates and modified Poisson regression models were used to assess the relationship between HPV awareness and HPV vaccine uptake, and sociodemographic characteristics. Results: Only 53% of participants had heard of HPV and 11.5% had received at least one dose of the HPV vaccine. Those who were female, non-Hispanic White or other, had public health insurance, lived above the federal poverty level, had experienced homelessness and incarceration, and had usual source of healthcare showed higher awareness of HPV while those who were younger, female, non-Hispanic White or other, recently incarcerated, had a usual source of healthcare, and had a healthcare encounter in the past year showed higher prevalence of HPV vaccine uptake. Conclusions: Prevalence of HPV vaccination in this high-risk population was low and there was a lack of preventive care utilization. Further research is needed on how to effectively target these populations to not only increase vaccine uptake, but to mitigate barriers that contribute to low awareness and suboptimal vaccination uptake in high-risk heterosexual populations.

Indexed as

Health disparitiesHPVHPV preventionHPV vaccinationHuman papillomavirus

Identifiers

PMID35733608
PMCPMC9207282
OpenAlexW4281755329

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.